TerminatedNot Applicable

In Vitro Maturation (IVM) of Human Oocytes

Stopped: Low accrual

United States2 participantsStarted 2012-02-15

Plain-language summary

The objectives of this study are to evaluate the clinical efficacy of Natural in vitro Fertilization and in vitro maturation.

Age range25 Years – 42 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Each subject must be female.
✓. Each subject must have an indication for COH and IVF with or without ICSI.
✓. Each subject must be willing and able to provide written informed consent for the trial
✓. Each subject must be 25 to ≤42 years of age at the time of signing informed consent.
✓. Each subject must have a normal cervical smear result (no atypical or abnormal cells, or in case of atypical squamous or glandular cells, no signs of malignancy; corresponding to Papanicolaou \[PAP\] I or II) obtained within 12 months prior to signing informed consent must be available

✕. Subject with premature ovarian failure
✕. Subject with endocrine abnormalities such as hyperprolactinaemia or thyroid dysfunction
✕. Subject with malformation or absence of uterus
✕. Subject has tested positive for Human Immunodeficiency Virus (HIV) or Hepatitis B (by local laboratory; results obtained within 1 year prior to signing ICF are considered valid).
✕. Subject with contraindication or allergy/hypersensitivity to hCG, estrogen and progesterone

number of oocytes retrieved and embryos generated

Timeframe: 1 year

NCT IDNCT01550861

SponsorWeill Medical College of Cornell University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-10-15